Letter: Severity‐Informed Enrichment for Recurrent Acute Pancreatitis Trials. Authors' Reply
Alimentary Pharmacology & Therapeutics · 2026-10 · 64 (7) · 1019-1020
DOI: 10.1111/apt.70854 ↗Kurz gefasst
Leserbrief in der Zeitschrift Alimentary Pharmacology & Therapeutics, online erschienen am 10.07.2026. Verfasst von Søren S Olesen und 1 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Pancreatic Diseases and Mech-Sense, Department of Gastroenterology and Hepatology, Aalborg University Hospital, Aalborg, Denmark. Die Arbeit nennt 5 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Centre for Pancreatic Diseases and Mech-Sense, Department of Gastroenterology and Hepatology, Aalborg University Hospital, Aalborg, Denmark.
- Department of Clinical Medicine, Aalborg University, Aalborg, Denmark.
ORCID-Profile: Søren S Olesen, Asbjørn M Drewes
Zitieren
APA
Olesen, S. S., & Drewes, A. M. (2026). Letter: Severity‐Informed Enrichment for Recurrent Acute Pancreatitis Trials. Authors' Reply. Alimentary Pharmacology & Therapeutics, 64(7), 1019-1020. https://doi.org/10.1111/apt.70854
Vancouver
Olesen SS, Drewes AM. Letter: Severity‐Informed Enrichment for Recurrent Acute Pancreatitis Trials. Authors' Reply. Alimentary Pharmacology & Therapeutics. 2026;64(7):1019-1020. doi:10.1111/apt.70854
BibTeX
@article{Olesen2026,
author = {Olesen, Søren S and Drewes, Asbjørn M},
title = {Letter: Severity‐Informed Enrichment for Recurrent Acute Pancreatitis Trials. Authors' Reply},
journal = {Alimentary Pharmacology & Therapeutics},
year = {2026},
volume = {64},
number = {7},
pages = {1019--1020},
doi = {10.1111/apt.70854}
}
EUVIMED